Covered vs. uncovered stents for transjugular intrahepatic portosystemic shunt: A randomized controlled trial

Journal of Hepatology

Volumn 60, Issue 5, 2014, Pages 962-968

  Perarnau, Jean Marc ^a   Le Gouge, Amélie ^b,c   Nicolas, Charlotte ^a,d   D'Alteroche, Louis ^a   Borentain, Patrick ^e   Saliba, Faouzi ^f   Minello, Anne ^g   Anty, Rodolphe ^b,h,i   Chagneau Derrode, Carine ^j   Bernard, Pierre Henri ^k   Abergel, Armand ^l   Ollivier Hourmand, Isabelle ^m   Gournay, Jérome ⁿ   Ayoub, Jean ^a   Gaborit, Christophe ^o   Rusch, Emmanuel ^o   Giraudeau, Bruno ^b,c,d  

^a SERVICE DE DERMATOLOGIE   (France)

^b INSERM   (France)

^c UNIVERSITY HOSPITAL OF TOURS   (France)

^d UNIVERSITÉ DE TOURS   (France)

^e HÔPITAL DE LA CONCEPTION   (France)

^f HÔPITAL PAUL BROUSSE   (France)

^g DIJON UNIVERSITY HOSPITAL   (France)

^h UNIVERSITY HOSPITAL OF NICE   (France)

ⁱ UNIVERSITÉ CÔTE D'AZUR   (France)

^j POITIERS UNIVERSITY HOSPITAL   (France)

^k BORDEAUX UNIVERSITY HOSPITAL   (France)

^l UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^m CAEN UNIVERSITY HOSPITAL   (France)

ⁿ NANTES UNIVERSITY HOSPITAL   (France)

^o CHU BRETONNEAU   (France)

more..

Author keywords

Ascites; Cirrhosis; Hepatic encephalopathy; Hydrothorax; Portal hypertension; Stent dysfunction; Variceal bleeding prevention

Indexed keywords

ADVERSE EFFECTS; AGED; ASCITES; CARCINOMA, HEPATOCELLULAR; CLINICAL TRIAL; COMPLICATION; CONTROLLED STUDY; DEVICES; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; HEPATIC ENCEPHALOPATHY; HUMAN; HYPERTENSION, PORTAL; KAPLAN MEIER METHOD; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MULTICENTER STUDY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SINGLE BLIND PROCEDURE; STENT; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT; TREATMENT OUTCOME;

AGED; ASCITES; CARCINOMA, HEPATOCELLULAR; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; HEPATIC ENCEPHALOPATHY; HUMANS; HYPERTENSION, PORTAL; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; RECURRENCE; SINGLE-BLIND METHOD; STENTS; TREATMENT OUTCOME;

EID: 84898832119     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2014.01.015     Document Type: Article

References (24)

1. M. Rössle, K. Haag, A. Ochs, M. Sellinger, G. Nöldge, and J.M. Perarnau et al. The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding N Engl J Med 20 1994 165 171
2. F. Salerno, C. Cammà, M. Enea, M. Rössle, and F. Wong Transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis of individual patient data Gastroenterology 133 2007 825 834
3. P. Ginès, J. Uriz, B. Calahorra, G. Garcia-Tsao, P.S. Kamath, and L.R. Del Arbol et al. Transjugular intrahepatic portosystemic shunting vs. paracentesis plus albumin for refractory ascites in cirrhosis Gastroenterology 123 2002 1839 1847
4. J.C. García-Pagán, K. Caca, C. Bureau, W. Laleman, B. Appenrodt, and A. Luca et al. Early use of TIPS in patients with cirrhosis and variceal bleeding N Engl J Med 362 2010 2370 2379
5. M. Casado, J. Bosch, J.C. García-Pagán, C. Bru, R. Bañares, and J.C. Bandi et al. Vienna TIPS Study Group Hepatology. Clinical events after transjugular intrahepatic portosystemic shunt: correlation with hemodynamic findings Gastroenterology 114 1998 1296 1303
6. C.D. Lind, T.W. Malisch, W.K. Chong, W.O. Richards, C.W. Pinson, and S.G. Meranze et al. Incidence of shunt occlusion or stenosis following transjugular intrahepatic portosystemic shunt placement Gastroenterology 106 1994 1277 1283
7. Z.J. Haskal, M.J. Pentecost, M.C. Soulen, R.D. Shlansky-Goldberg, R.A. Baum, and C. Cope Transjugular intrahepatic portosystemic shunt stenosis and revision: early and midterm results Am J Roentgenol 163 1994 439 444
8. A.J. Sanyal, A.M. Freedman, V.A. Luketic, P.P. Purdum 3rd, M.L. Shiffman, and J. DeMeo et al. The natural history of portal hypertension after transjugular intrahepatic portosystemic shunts Gastroenterology 112 1997 889 898
9. Z.J. Haskal Improved patency of transjugular intrahepatic portosystemic shunts in humans: creation and revision with PTFE stent-grafts Radiology 213 1999 759 766
10. R.T. Andrews, R.R. Saxon, R.D. Bloch, B.D. Petersen, B.T. Uchida, and J.M. Rabkin et al. Stent-grafts for de novo TIPS: technique and early results J Vasc Interv Radiol 10 1999 1371 1378
11. B. Angermayr, M. Cejna, F. Koenig, F. Karnel, F. Hackl, and A. Gangl et al. Survival in patients undergoing transjugular intrahepatic portosystemic shunt: ePTFE-covered stentgrafts vs. bare stents Hepatology 38 2003 1043 1050
12. P. Rossi, F.M. Salvatori, F. Fanelli, M. Bezzi, M. Rossi, and G. Marcelli et al. Polytetrafluoroethylene-covered nitinol stent-graft for transjugular intrahepatic portosystemic shunt creation: 3-year experience Radiology 231 2004 820 830
13. J. Barrio, C. Ripoll, R. Bañares, A. Echenagusia, M.V. Catalina, and F. Camúñez et al. Comparison of transjugular intrahepatic portosystemic shunt dysfunction in PTFE-covered stent-grafts vs. bare stents Eur J Radiol 55 2005 120 124
14. D. Tripathi, J. Ferguson, H. Barkell, K. Macbeth, H. Ireland, and D.N. Redhead et al. Improved clinical outcome with transjugular intrahepatic portosystemic stent-shunt utilizing polytetrafluoroethylene-covered stents Eur J Gastroenterol Hepatol 18 2006 225 232
15. C. Bureau, J.C. Garcia-Pagan, P. Otal, G. Pomier-Layrargues, V. Chabbert, and C. Cortez et al. Improved clinical outcome using polytetrafluoroethylene- coated stents for TIPS: results of a randomized study Gastroenterology 126 2004 469 475
16. C. Bureau, J.C. Pagan, G.P. Layrargues, S. Metivier, P. Bellot, and P. Perreault et al. Patency of stents covered with polytetrafluoroethylene in patients treated by transjugular intrahepatic portosystemic shunts: long-term results of a randomized multicentre study Liver Int 27 2007 742 747
17. R. De Franchis Evolving consensus in portal hypertension. Report of the BavenoIV consensus workshop on methodology of diagnosis and therapy in portal hypertension J Hepatol 43 2005 167 176
18. A. Latouche, R. Porcher, and S. Chevret Sample size formula for proportional hazards modelling of competing risks Stat Med 23 2004 3263 3274
19. D. Fergusson, S.D. Aaron, G. Guyatt, and P. Hébert Post-randomisation exclusions: the intention to treat principle and excluding patients from analysis BMJ 325 2002 652 654
20. J.P. Fine, and R.J. Gray A proportional hazard model for the subdistribution of a competing risk J Am Stat Assoc 94 1999 496 509
21. O. Riggio, L. Ridola, S. Angeloni, F. Cerini, C. Pasquale, and A.F. Attili et al. Clinical efficacy of transjugular intrahepatic portosystemic shunt created with covered stents with different diameters: results of a randomized controlled trial J Hepatol 53 2010 267 272
22. M. Rössle, and A.L. Gerbes TIPS for the treatment of refractory ascites, hepatorenal syndrome and hepatic hydrothorax: a critical update Gut 59 2010 988 1000
23. J.J. Pan, C. Chen, B. Geller, R. Firpi, V.I. Machicao, and J.G. Caridi et al. Is sonographic surveillance of polytetrafluoroethylene-covered transjugular intrahepatic portosystemic shunts (TIPS) necessary? A single centre experience comparing both types of stents Clin Radiol 63 2008 1142 1148
24. K.C. Sajja, B.L. Dolmatch, and D.C. Rockey Long-term follow-Up of TIPS created with expanded poly-tetrafluoroethylene covered stents Dig Dis Sci 58 2013 2100 2106